Evofem Biosciences Reports Third Quarter 2018 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/23/2026

1. USO
2. META
3. NVDA
4. SPY
5. DCOY
6. MSFT
7. VKTX
8. PRGS
9. PSKY
10. DGX

Go back to Evofem Biosciences Reports Third Quarter 2018 Financial Results and Provides Corporate Update

Evofem Biosciences (EVFM) Misses Q3 EPS by 34c

November 7, 2018 6:54 AM EST

Evofem Biosciences (NASDAQ: EVFM) reported Q3 EPS of ($0.71), $0.34 worse than the analyst estimate of ($0.37).

"We have made significant progress this quarter in our clinical programs evaluating Amphora for critical areas in women's health where current options are either insufficient or absent entirely," said... More